Prix Galien 2021 – Press release (english / french)
17 December, 2021
In medical device section, the Prix Galien 2021 awarded to TITAN OPTIMAX® (HEXACATH), a bioactive coronary stent coated with Titanium-Nitride-Oxide.
Prix Galien 2021 – Press release (french)
17 December, 2021
In medical device section, the Prix Galien 2021 awarded to TITAN OPTIMAX® (HEXACATH), a bioactive coronary stent coated with Titanium-Nitride-Oxide.
Prix Galien 2021 – Press kit extract (french)
17 December, 2021
France is responsible for the initiative to have created in 1970 a pharmaceutical research prize, the Prix Galien, whose reputation and influence have since made it the world’s most prestigious award.
OPTIMAX MDR Certification
27 October, 2021
HEXACATH Obtains one of the World first MDR certification for a Class III Coronary Stent Medical Device.
HEXACATH is proud to announce the certification of its TITAN OPTIMAX (bioactive coronary stent coated with Titanium-Nitride-Oxide) according to the New European Regulation (EU) 2017/745 for CE marking.